Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
TORONTO, ON / ACCESSWIRE / January 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), is a...
Pharmaceutical
Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery,...
Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
Uncle Bud’s, PBIO’s New Consumer Products Business Unit, Kicks Off 2024 with a $252,000 Shipment of Sunburn Soother to One of...
NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client
Project reflects Scorpius’ versatility through its multi-functional biologics facility and expertise in microbial fermentationDURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE)...
Instil Bio Announces Strategic Update
DALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company...
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
Accelerating Healthcare With Award-Winning AI: Big Steps Forward In 2023 And The Early Days Of 2024LOS ANGELES, Jan. 16, 2024...
Panbela Announces 1-for-20 Reverse Stock Split Effective January 18, 2024
MINNEAPOLIS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of...
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
Limited Market Release of First Purpose-Built OR Product to Begin in First Half of 2024 SmartFrame OR™ Stereotactic Systemwww.clearpointneuro.com SOLANA...
Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now includes 17 issued patents...
Biora Therapeutics Provides Outlook for 2024
Multiple catalysts anticipated in 2024, including clinical study results for NaviCap™ Targeted Oral Delivery Platform and progress on pharma partnerships...
60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements
WASHINGTON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical...
Single Use Support continues to grow, expanding its team by 40%
Innovative process solution provider Single Use Support continues to deliver strong organic growth, supported by an expansion in its employee...
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
MALVERN, Pa., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
Placebo-controlled Phase 2 trial cleared by the FDA – Trial to begin in Q2 2024 Trial to include Schizophrenia validated...
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
NEW YORK and VIENNA, Austria, Jan. 16, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Hemogenyx Pharmaceuticals PLC Announces Submission of Complete Response to Clinical Hold
Submission of Complete Response to Clinical Hold for HEMO-CAR-T INDLONDON, UK / ACCESSWIRE / January 16, 2024 / Hemogenyx Pharmaceuticals...
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.
BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD, MBA...
Red Light Holland Receives Building Permit for AEM Farms 80,000 Square Foot Mushroom Farm, Adding Substantial Future Production Capacity
New multi million dollar production facility will increase AEM Farm's mushroom production output by approximately 15-18 million dollars of domestic...
Theralase(R) Provides Update on Phase II Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / January 15, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...
ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids
New subgroup analysis from STRATUM study shows that individuals with an inadequate response, contraindication, or intolerance to steroids were 3.5...